We are constantly hearing about possible ways to control prostate cancer through diet. Often, researchers point out that in Asian cultures, even in the cultures that have a similar rate of prostate cancer, the disease seems to progress in Western cultures, but not in the Asian cultures. A University of Colorado Cancer Center study published [...]
I have said many times that one of the more important issues facing our use of Provenge is when to start it and how to sequence this treatment with the other newly approved agents that have recently become available for men with advanced prostate cancer. There is occasional conversation that Provenge is already antiquated due [...]
Everyone knows that exercise is good for both people with and without cancer, including advanced prostate cancer. For us advanced prostate cancer survivors, going on and off therapy probably makes exercise evn more important than for the general population. It is well known that people with stronger, leaner bodies have more energy, are healthier and [...]
Sipuleucel-T (Provenge) is FDA approved after a man becomes castrate resistant. In clinical trials it has shown that it extends life when compared to placebo. The use of Provenge has raised many questions, the two most common ones are why PSA and disease progression continues while receiving this treatment (see post at for an explanation) [...]
There are now two new, additional sites added to the Early Access Trial of the investigational treatment known as Radium-233 or Alpharadin for men with castrate resistant prostate cancer with multiple bone metastases. This post contains the most up to date and accurate information, the clinical trials.gov site is NOT currently accurate. Additionally, there are [...]